The CDCs Advisory Committee on Immunization Practices announced its recommended 2014 adult immunization schedule.
The ACIP is comprised of the American College of Physicians and 16 other medical societies representing various medical practice areas. The ACIP reviews the CDCs Recommended Adult Immunization Schedule each year to ensure the schedule reflects current clinical recommendations for licensed vaccines. The recommendations are intended to guide clinicians about the appropriate vaccines for their adult patients.
Influenza: Information on the use of the recombinant influenza and inactivated influenza vaccines among egg-allergic patients was added to the footnote and indicates that RIV or IIV can be used among persons with hives-only allergy to eggs, as these vaccines contain no egg protein.
Td/Tdap: The tetanus, diphtheria, accellular pertussis and tetanus, diphtheria vaccines footnote was edited to harmonize with the language used in the pediatric immunization schedule. A single dose of Tdap vaccine is recommended for previously unvaccinated persons ages 11 or older, and Td booster should be administered every 10 years thereafter.
HPV: Information was added to the human papillomavirus vaccine footnote to clarify the timing between the second and third doses and to harmonize language between the pediatric and adult immunization schedules. No changes in recommendations were made.
Zoster: Being a healthcare worker is no longer an indication for vaccination. This change was also made to the HPV vaccine footnote.
PCV13: Because PCV13 is recommended to be administered before PPSV23 among individuals for whom both vaccines are recommended, the PCV13 footnote now precedes the PPSV23 footnote and includes wording to remind providers of the appropriate order of these vaccines when both are indicated.
The meningococcal vaccine footnote was edited to clarify which individuals need either one or two doses of vaccine and to provide greater clarity regarding which patients should receive meningococcal conjugate versus the meningococcal polysaccharide.
Hib: The Haemophilus influenza type b vaccine recommendations were updated. The vaccine is recommended for certain adults at increased risk for Hib who have not received the vaccine before, except for those with HIV because their risk for Hib infection is low. Adults who have had successful hematopoietic stem cell transplant are recommended to receive a three-dose series of Hib vaccine six to 12 months after the transplant regardless of prior Hib vaccination status.
Complete schedule: http://annals.org/article.aspx?articleid=1819123